| |
|
| |
| Links: |
Consumer response to walk-in clinics or retail clinics has been optimistic, which has led to an upsurge in the number of retail clinics in recent past, witnessing robust growth and outlet scope. According to a survey conducted in the US in 2016,
More than 36% of the retail clinic customer pool was satisfied with the services and other aspects of walk-in clinics.
Approximately 54% of the adult population that first visited a retail clinic highly recommend the services provided by retail clinics.
A negligible percentage among them reported that they were not satisfied with the offerings of retail clinics.
On the other side, according to a recent Walmart Survey, nearly 90% of the customers were satisfied with retail clinics and the high satisfaction level has been attributed to cost transparency, surpassing the conventional benefit of cost efficiency.
According to a recent study, the global market for retail clinics will grow at a strong CAGR of over 10% during 2018-2028 and is likely to continue most prominent expansion in the US owing to positive consumer demand response within a short span of time.

Increasing Number of Retail Clinics and Rising Frequency of Visits for Low-Acuity Medical Conditions
Retail clinics have been considered by insurers and policy makers as an alternative way to reduce healthcare spending. Clinic visits cost way less than physician office or emergency department visits. According to a survey conducted by the RAND organization, approximately 58% of retail clinic visits account for low-acuity conditions that represent new utilization.
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9254
The use of retail clinics is associated with a decent increment in healthcare spending. Similar researches and studies around the globe have shown that approximately 40% of retail clinic visits are for minor medical issues. This increase in spending from higher use of services outweighs the savings generated when consumers went to less expensive retail clinics instead of an emergency room or a doctor's office.
In the US, where retail clinics are extremely widespread, the first retail clinics opened in Minnesota in 2000. However, as per the RAND study conducted in November 2011, the number of retail clinics increased by a factor of 12 between 2006 and 2010. Retail clinic visits, majorly for low-acuity conditions, have led to an increase in spending and utilization, further fuelling demand growth of the retail clinics market during the forecast period.
Growth of Retail Clinics in Vaccination Delivery
Retail clinics have shown promising growth in vaccination delivery, majorly in the United States. Vaccinations hold a substantial share of the retail clinics business. The trend of vaccination delivery has observed decent growth in the overall market for retail clinics. However, retail clinics could deliver more vaccinations and increase their overall business if the vaccination histories are reviewed and the patients are counselled on the advantages of vaccination during acute care visits.
Retail clinics are considered to be a promising venue both for promoting and administering vaccinations. As most retail clinics are located in popular locations, such as hypermarkets, supermarkets, grocery stores, the advertising and promotion of vaccinations becomes easy.
Increase in Healthcare Expenditure
Globally, the per capita spending on healthcare has been increasing. People’s desire and ability to spend on wellness have led to an incremental shift in healthcare expenditure, which is expected to boost the growth of medical and healthcare industries, and subsequently, medical treatment in the near future. Within a span of 10 years, the global per capita healthcare spending has almost doubled, owing to the increasing awareness regarding the availability of treatment options in the market.
For instance, healthcare expenditure in percentage with GDP grew from 17.2% to 17.3% from 2016 to 2018 in the US. Europe has been registering a consistent increase in healthcare expenditure in regions such as France, Germany, the Netherlands, Denmark and Switzerland and had a GDP% healthcare expenditure of 11.7%, 11.3%, 12.9%, 10.6% and 11.5% respectively.
Definition
Retail clinics are also termed as walk-in clinics, owing to the convenience they provide to patients. These clinics are located inside retail stores, such as department stores, hypermarkets and supermarkets. Retail clinics come under a broader category termed as convenient care centres. Retail clinics take care of different injuries and illnesses. In addition, majority of medical conditions that are treated at any traditional facility, could also be treated at these retail clinics.
About the Report
FMI conducted a research study on the retail clinics market for the forecast period 2018 to 2028. The report offers a comprehensive evaluation of the business opportunities prevailing in the retail clinics market, along with insights on the retail clinics market value analysis base by region, market trends, pricing analysis based on service type, reimbursement scenario, target population for retail clinics, consumer sentiment analysis, existing models for retail clinics, and costs per patient visit comparison. The retail clinics market report elaborates on the macro-economic factors influencing the dynamics of the market, and its futuristic potential.
Request to View Methodology @ https://www.futuremarketinsights.com/askus/rep-gb-9254
Retail Clinics Market: Segmentation
The report on the retail clinics market offers a comprehensive taxonomy of the retail clinics market based on application, distribution channel, ownership type, and region.
The retail clinics market, on the basis of application, has been segmented as point-of-care diagnostics, clinical chemistry and immunoassay, vaccinations, and others.
By distribution channel, the retail clinics market has been segmented into retail pharmacies, drug stores, and grocery chain and big box stores.
By ownership type, the retail clinics market has been segmented into retail-owned retail clinics and hospital-owned retail clinics.
Gastroesophageal Reflux Disease (GERD) Devices Market - Key Research Findings
Global gastroesophageal reflux disease devices market size in 2017 – Over US$ 970 Mn
The gastroesophageal reflux disease devices market will observe just-over 4% CAGR over 2018-2028
According to World Gastroenterology Organization,
There are reported differences in the prevalence of gastroesophageal reflux disease, ranging from 2.5% to 6.6% in Asia up to 13.8% to 25.8% in North America.
North America will remain the largest regional markets for gastroesophageal reflux disease devices
Gastroesophageal reflux disease (GERD) is the most prevalent gastrointestinal disease in the US as the rate of obesity is very high.
The high rate of obesity in the US is one of the major factors contributing to the growth of gastroesophageal reflux disease devices market within North America.
Asia Pacific holds high growth potential for gastroesophageal reflux disease devices market
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1741
Increasing healthcare awareness and increasing establishments of diagnostic centres and hospitals prominently fuel the growth of gastroesophageal reflux disease devices market within APAC.
By product type, esophagoscopes and gastroscopes, hold the maximum market share in the gastroesophageal reflux disease devices market.
The diagnostic devices as a segment of gastroesophageal reflux disease devices market covers esophageal manometry system and PH monitoring device.
The treatment devices, which is another key segment of gastroesophageal reflux disease devices market, cover ultrasonic surgical endostapler, fundoplication gastroesophageal reflux disease devices, sphincter augmentation gastroesophageal reflux disease devices, and radiofrequency ablation gastroesophageal reflux disease devices.

Top 3 Factors Shaping Gastroesophageal Reflux Disease Devices Market
Increasing Prevalence of Abdominal Obesity Continues to Drive Demand for Gastroesophageal Reflux Disease Devices Market
The increasing prevalence of gastroesophageal reflux disease is correlated with the increasing prevalence of obesity in many countries and presence of other poor diet and lifestyle factors. This increases the demand of gastroesophageal reflux disease devices. The difference in the prevalence of gastroesophageal reflux does not depend on the gender, but males are expected to face a higher rate of complications, associated with the disease. The prevalence or gastroesophageal generally increases with age, particularly after age 40.
Increasing Geriatric Population Remains among Primary Boosters for Growth of Gastroesophageal Reflux Disease Devices Market
Esophagus malfunctioning in the geriatric population is associated with the disturbances associated with esophageal motility and a decreased production of saliva. Increasing geriatric population will thus remain an important factor driving the gastroesophageal reflux disease devices market. Some of the frequently consumed medications such as bisphosphonates, non-steroidal anti-inflammatory drugs (NSAIDs), and potassium tablets often affect the esophageal motility and the lower esophageal sphincter’s functionality, which in turn is responsible for demand growth of of gastroesophageal reflux disease devices.
Sedentary Lifestyle Shift Continues to Push Demand for Gastroesophageal Reflux Diseases Devices
Several environmental factors and the prominent lifestyle evolution to sedentary habits such as a high dietary fat intake, shorter dinner-to-bed time, and frequent smoking and alcohol consumption have been proven as the high risk factors associated with the prevalence of gastroesophageal reflux diseases. Lack of adequate physical activity, coupled with increasing body mass index and obesity, are likely to continue fueling the instances of gastroesophageal reflux diseases, thereby generating demand for GERD devices.
Request to View Methodology @ https://www.futuremarketinsights.com/askus/rep-gb-1741
Gastroesophageal Reflux Disease Devices Market Structure Analysis
The global gastroesophageal reflux disease devices market represents a consolidated competition landscape, wherein Tier 1 companies hold more than 70% revenue share.
Top companies in the gastroesophageal reflux disease devices market include Olympus Corporation, Pentax Medical, KARL STORZ SE & Co KG., Medtronic Plc, and Fujifilm Holdings Corporation.
While most of the key players maintain strategic focus on the partnerships with other companies and also distribution expansion of various products in different geographies.
Leading players in gastroesophageal reflux disease devices market are also concentrating on technological innovation for the better treatment of gastroesophageal reflux diseases.
Cerium is a very soft and ductile metal which oxidizes very easily in the air. The metallic cerium is manufactured using metallothermic process which in turns gives cerium of higher purity. Cerium is used as catalysts and adhesives in numerous commercial applications. Cerium exhibits properties similar to that of calcium and accumulates in the bones in small amounts. Cerium can be found in small amounts in barley and tobacco plants.
The market for cerium was mainly driven by the growing demand for rare earth metal catalysts from various manufacturing sectors. In addition, there is huge demand for cerium in China and other Asian countries. Cerium is used in various applications such as polishing powder, adding colors in ceramics and glass, flints in lighters and in self-cleaning ovens. More exploration of unmined reserves and recycling of cerium metal from e-waste can provide opportunities for the market. However, the fluctuating prices in the market are likely to act as restraint in near future. Furthermore, over dependency of global cerium market on China can act as a major restraint to the market.
Request For Report Sample@ https://www.persistencemarketresearch.com/samples/4406
In terms of demand, Asia Pacific is the leading region for cerium market. The demand for cerium is significant from China and Japan. Growing demand from electronics sector in this region is likely to be one of the major drivers for the cerium market. North America market is likely to grow in near future owing to various manufacturing techniques and decreasing dependency on China for the cerium. Increasing demand in North America has lead to increased number of explorations and investments in this region. Europe is likely to be stable market for cerium and will follow similar trend in near future. The Rest of the World market is anticipated to have average demand for cerium in near future.
Request For Report Table of Content (TOC):https://www.persistencemarketresearch.com/toc/4406
Some of the key providers in the cerium market are Avalon Rare Metals Inc, China Minmetals Rare Earth Co. Ltd., Baotou Hefa Rare Earth Co. Ltd. and Lynas Corporation Ltd. among others.
(Added: Wed Jun 05 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate ItGastroesophageal Reflux Disease (GERD) Devices Market - Key Research Findings
Global gastroesophageal reflux disease devices market size in 2017 – Over US$ 970 Mn
The gastroesophageal reflux disease devices market will observe just-over 4% CAGR over 2018-2028
According to World Gastroenterology Organization,
There are reported differences in the prevalence of gastroesophageal reflux disease, ranging from 2.5% to 6.6% in Asia up to 13.8% to 25.8% in North America.
North America will remain the largest regional markets for gastroesophageal reflux disease devices
Gastroesophageal reflux disease (GERD) is the most prevalent gastrointestinal disease in the US as the rate of obesity is very high.
The high rate of obesity in the US is one of the major factors contributing to the growth of gastroesophageal reflux disease devices market within North America.
Asia Pacific holds high growth potential for gastroesophageal reflux disease devices market
Increasing healthcare awareness and increasing establishments of diagnostic centres and hospitals prominently fuel the growth of gastroesophageal reflux disease devices market within APAC.
By product type, esophagoscopes and gastroscopes, hold the maximum market share in the gastroesophageal reflux disease devices market.
The diagnostic devices as a segment of gastroesophageal reflux disease devices market covers esophageal manometry system and PH monitoring device.
The treatment devices, which is another key segment of gastroesophageal reflux disease devices market, cover ultrasonic surgical endostapler, fundoplication gastroesophageal reflux disease devices, sphincter augmentation gastroesophageal reflux disease devices, and radiofrequency ablation gastroesophageal reflux disease devices.
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1741

Top 3 Factors Shaping Gastroesophageal Reflux Disease Devices Market
Increasing Prevalence of Abdominal Obesity Continues to Drive Demand for Gastroesophageal Reflux Disease Devices Market
The increasing prevalence of gastroesophageal reflux disease is correlated with the increasing prevalence of obesity in many countries and presence of other poor diet and lifestyle factors. This increases the demand of gastroesophageal reflux disease devices. The difference in the prevalence of gastroesophageal reflux does not depend on the gender, but males are expected to face a higher rate of complications, associated with the disease. The prevalence or gastroesophageal generally increases with age, particularly after age 40.
Increasing Geriatric Population Remains among Primary Boosters for Growth of Gastroesophageal Reflux Disease Devices Market
Esophagus malfunctioning in the geriatric population is associated with the disturbances associated with esophageal motility and a decreased production of saliva. Increasing geriatric population will thus remain an important factor driving the gastroesophageal reflux disease devices market. Some of the frequently consumed medications such as bisphosphonates, non-steroidal anti-inflammatory drugs (NSAIDs), and potassium tablets often affect the esophageal motility and the lower esophageal sphincter’s functionality, which in turn is responsible for demand growth of of gastroesophageal reflux disease devices.
Sedentary Lifestyle Shift Continues to Push Demand for Gastroesophageal Reflux Diseases Devices
Several environmental factors and the prominent lifestyle evolution to sedentary habits such as a high dietary fat intake, shorter dinner-to-bed time, and frequent smoking and alcohol consumption have been proven as the high risk factors associated with the prevalence of gastroesophageal reflux diseases. Lack of adequate physical activity, coupled with increasing body mass index and obesity, are likely to continue fueling the instances of gastroesophageal reflux diseases, thereby generating demand for GERD devices.
Request to View Methodology @ https://www.futuremarketinsights.com/askus/rep-gb-1741
Gastroesophageal Reflux Disease Devices Market Structure Analysis
The global gastroesophageal reflux disease devices market represents a consolidated competition landscape, wherein Tier 1 companies hold more than 70% revenue share.
Top companies in the gastroesophageal reflux disease devices market include Olympus Corporation, Pentax Medical, KARL STORZ SE & Co KG., Medtronic Plc, and Fujifilm Holdings Corporation.
While most of the key players maintain strategic focus on the partnerships with other companies and also distribution expansion of various products in different geographies.
Leading players in gastroesophageal reflux disease devices market are also concentrating on technological innovation for the better treatment of gastroesophageal reflux diseases.
Pages: [<<] ... 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 ... [>>]
Links SQL By: Gossamer Threads Inc.